CVS CVS Health
NYSE · SEC CIK 64803 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $323.70M 2 sales by 2 insiders
- Filings on record
- 285 since 2021-08-05, latest 2026-06-29 15:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ROBBINS LARRY | Dir | — | $317.47M |
| Mandadi Tilak | EVP, Chief Exp, Tech Off | — | $6.23M |
| Shah Prem S | EVP, Group Pres | — | — |
| Newman Brian | EVP, CFO | — | — |
| Clark James David | SVP, Cont, Chief Acct Off | — | — |
| Balser Jeffrey R. | Dir | — | — |
| Compton-Phillips Amy | EVP, Chief Medical Off | — | — |
| Shulman Douglas H. | Dir | — | — |
| CAPOZZI HEIDI B | EVP, CHRO | — | — |
| Khichi Samrat S. | EVP, GC, CPO | — | — |
Transactions 264
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-29 15:11 | 2026-06-26 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $90.98 | -454 | 27.6K | -2% | -$41.3K | |
| 2026-06-01 17:02 | 2026-05-31 | CVS | Newman Brian | EVP, CFO | F - Tax | $90.98 | -2,478 | 3,008 | -45% | -$225.4K | |
| 2026-06-01 17:00 | 2026-05-31 | CVS | Compton-Phillips Amy | EVP, Chief Medical Off | F - Tax | $90.98 | -7,618 | 9,557 | -44% | -$693.1K | |
| M | 2026-05-22 17:39 | 2026-05-20+ | CVS | AGUIRRE FERNANDO | Dir | D - Sale to Iss | $93.76 | -32.0K | 10.5K | -75% | -$3.00M |
| DMI | 2026-05-21 17:43 | 2026-05-19+ | CVS | ROBBINS LARRY | Dir | S - Sale | $94.15 | -3.37M | 4.82M | -41% | -$317.47M |
| 2026-05-15 17:20 | 2026-05-14 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $97.15 | +1,563 | 42.5K | +4% | +$151.8K | |
| 2026-05-15 17:19 | 2026-05-14 | CVS | Balser Jeffrey R. | Dir | A - Grant | $97.15 | +2,058 | 15.7K | +15% | +$199.9K | |
| 2026-05-15 17:14 | 2026-05-14 | CVS | KIRBY J SCOTT | Dir | A - Grant | $97.15 | +1,447 | 14.4K | +11% | +$140.6K | |
| 2026-05-15 17:12 | 2026-05-14 | CVS | Norwalk Leslie V | Dir | A - Grant | $97.15 | +1,447 | 7,376 | +24% | +$140.6K | |
| 2026-05-15 17:11 | 2026-05-14 | CVS | SANSONE GUY P | Dir | A - Grant | $97.15 | +1,447 | 15.1K | +11% | +$140.6K | |
| 2026-05-15 17:07 | 2026-05-14 | CVS | BROWN C DAVID II | Dir | A - Grant | $97.15 | +1,544 | 129.3K | +1% | +$150.0K | |
| 2026-05-11 17:27 | 2026-05-08 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | S - Sale | $89.58 | -69.6K | 10.1K | -87% | -$6.23M | |
| D | 2026-04-02 16:58 | 2026-03-31 | CVS | Shah Prem S | EVP, Group Pres | A - Grant | $71.82 | +25.1K | 62.9K | +66% | +$1.80M |
| D | 2026-04-02 16:58 | 2026-04-01 | CVS | Shah Prem S | EVP, Group Pres | F - Tax | $72.49 | -1,484 | 64.4K | -2% | -$107.6K |
| D | 2026-04-02 16:57 | 2026-03-31 | CVS | Newman Brian | EVP, CFO | A - Grant | $71.82 | +19.5K | 41.4K | +89% | +$1.40M |
| D | 2026-04-02 16:56 | 2026-03-31 | CVS | Nelson Steven H | EVP, Pres, Aetna | A - Grant | $71.82 | +22.3K | 43.6K | +104% | +$1.60M |
| D | 2026-04-02 16:56 | 2026-04-01 | CVS | Nelson Steven H | EVP, Pres, Aetna | F - Tax | $72.49 | -2,432 | 2,900 | -46% | -$176.3K |
| D | 2026-04-02 16:55 | 2026-03-31 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | A - Grant | $71.82 | +22.3K | 88.5K | +34% | +$1.60M |
| D | 2026-04-02 16:55 | 2026-04-01 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | F - Tax | $72.49 | -3,634 | 79.7K | -4% | -$263.4K |
| D | 2026-04-02 16:54 | 2026-03-31 | CVS | Khichi Samrat S. | EVP, GC, CPO | A - Grant | $71.82 | +12.5K | 38.1K | +49% | +$900.0K |
| D | 2026-04-02 16:54 | 2026-04-01 | CVS | Khichi Samrat S. | EVP, GC, CPO | F - Tax | $72.49 | -3,541 | 33.4K | -10% | -$256.7K |
| 2026-04-02 16:52 | 2026-03-31 | CVS | Joyner J. David | Pres, CEO, COB, Dir | A - Grant | $71.82 | +86.3K | 160.9K | +116% | +$6.20M | |
| 2026-04-02 16:52 | 2026-04-01 | CVS | Joyner J. David | Pres, CEO, COB, Dir | F - Tax | $72.49 | -8,029 | 70.3K | -10% | -$582.0K | |
| D | 2026-04-02 16:52 | 2026-03-31 | CVS | Compton-Phillips Amy | EVP, Chief Medical Off | A - Grant | $71.82 | +5,569 | 58.7K | +10% | +$400.0K |
| D | 2026-04-02 16:51 | 2026-03-31 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $71.82 | +11.1K | 35.5K | +46% | +$799.9K |
| D | 2026-04-02 16:51 | 2026-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $72.49 | -3,262 | 15.5K | -17% | -$236.5K |
| D | 2026-04-02 16:49 | 2026-03-31 | CVS | CAPOZZI HEIDI B | EVP, CHRO | A - Grant | $71.82 | +10.0K | 84.5K | +13% | +$720.0K |
| D | 2026-04-02 16:49 | 2026-04-01 | CVS | CAPOZZI HEIDI B | EVP, CHRO | F - Tax | $72.49 | -1,334 | 13.0K | -9% | -$96.7K |
| 2026-03-20 | 2026-03-19 | CVS | Gallina John E | Dir | A - Grant | $71.86 | +582 | 582 | New | +$41.8K | |
| 2026-03-02 | 2026-02-28 | CVS | Khichi Samrat S. | EVP, GC, CPO | F - Tax | $79.60 | -7,886 | 29.8K | -21% | -$627.7K | |
| 2026-03-02 | 2026-02-28 | CVS | Joyner J. David | Pres, CEO, Dir | F - Tax | $79.90 | -1,944 | 50.0K | -4% | -$155.3K | |
| I | 2026-01-27 | 2025-01-23 | CVS | Nelson Steven H | EVP, Pres, Aetna | P - Purchase | $53.70 | +24 | 24 | New | +$1,289 |
| 2026-01-05 | 2026-01-01 | CVS | Shah Prem S | EVP, Group Pres | F - Tax | $80.13 | -247 | 61.5K | -0.4% | -$19.8K | |
| 2025-12-02 | 2025-11-30 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | F - Tax | $80.36 | -6,575 | 74.1K | -8% | -$528.4K | |
| 2025-12-02 | 2025-12-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $79.10 | -220 | 24.4K | -0.9% | -$17.4K | |
| 2025-12-02 | 2025-11-30 | CVS | CAPOZZI HEIDI B | EVP, CHRO | F - Tax | $80.36 | -9,470 | 11.4K | -45% | -$761.0K | |
| 2025-12-02 | 2025-11-30 | CVS | FARAH ROGER N | Dir | F - Tax | $80.36 | -9,748 | 19.4K | -33% | -$783.3K | |
| 2025-11-21 | 2025-11-20 | CVS | SANSONE GUY P | Dir | A - Grant | $76.04 | +1,652 | 13.7K | +14% | +$125.6K | |
| D | 2025-11-21 | 2025-11-20 | CVS | Finucane Anne A. | Dir | A - Grant | $76.04 | +591 | 591 | New | +$44.9K |
| 2025-11-21 | 2025-11-20 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $76.04 | +1,800 | 41.0K | +5% | +$136.9K | |
| 2025-11-21 | 2025-11-20 | CVS | Shulman Douglas H. | Dir | A - Grant | $76.04 | +1,652 | 5,929 | +39% | +$125.6K | |
| 2025-11-21 | 2025-11-20 | CVS | KIRBY J SCOTT | Dir | A - Grant | $76.04 | +1,652 | 13.0K | +15% | +$125.6K | |
| 2025-11-21 | 2025-11-20 | CVS | BROWN C DAVID II | Dir | A - Grant | $76.04 | +1,775 | 127.8K | +1% | +$135.0K | |
| 2025-11-21 | 2025-11-20 | CVS | Norwalk Leslie V | Dir | A - Grant | $76.04 | +1,652 | 5,929 | +39% | +$125.6K | |
| 2025-11-21 | 2025-11-20 | CVS | Balser Jeffrey R. | Dir | A - Grant | $76.04 | +1,775 | 13.7K | +15% | +$135.0K | |
| MI | 2025-10-14 | 2024-09-09+ | CVS | CAPOZZI HEIDI B | EVP, CHRO | P - Purchase | $57.36 | +80 | 85 | +1,600% | +$4,589 |
| 2025-09-02 | 2025-08-31 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | F - Tax | $73.15 | -12.8K | 64.0K | -17% | -$938.8K | |
| 2025-09-02 | 2025-08-31 | CVS | Shah Prem S | EVP, Group Pres | F - Tax | $73.15 | -6,995 | 60.6K | -10% | -$511.7K | |
| I | 2025-08-29 | 2025-08-20 | CVS | Finucane Anne A. | Dir | S - Sale | $71.02 | -7,500 | 22.2K | -25% | -$532.6K |
| 2025-06-09 | 2025-06-05 | CVS | SANSONE GUY P | Dir | P - Purchase | $63.70 | +1,570 | 12.0K | +15% | +$100.0K | |
| DM | 2025-06-03 | 2025-05-31 | CVS | Compton-Phillips Amy | EVP, Chief Medical Off | A - Grant | $64.04 | +53.1K | 53.1K | New | +$3.40M |
| D | 2025-06-03 | 2025-05-31 | CVS | Newman Brian | EVP, CFO | A - Grant | $64.04 | +21.9K | 21.9K | New | +$1.40M |
| 2025-05-19 | 2025-05-15 | CVS | Norwalk Leslie V | Dir | A - Grant | $60.47 | +2,077 | 4,277 | +94% | +$125.6K | |
| D | 2025-05-19 | 2025-05-15 | CVS | Finucane Anne A. | Dir | A - Grant | $60.47 | +692 | 692 | New | +$41.8K |
| 2025-05-19 | 2025-05-15 | CVS | Shulman Douglas H. | Dir | A - Grant | $60.47 | +2,077 | 4,277 | +94% | +$125.6K | |
| D | 2025-05-19 | 2025-05-15 | CVS | Mahoney Michael F | Dir | A - Grant | $60.47 | +144 | 6,345 | +2% | +$8,708 |
| 2025-05-19 | 2025-05-15 | CVS | BROWN C DAVID II | Dir | A - Grant | $60.47 | +2,232 | 126.0K | +2% | +$135.0K | |
| 2025-05-19 | 2025-05-15 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $60.47 | +2,263 | 39.1K | +6% | +$136.8K | |
| 2025-05-19 | 2025-05-15 | CVS | KIRBY J SCOTT | Dir | A - Grant | $60.47 | +2,769 | 11.3K | +32% | +$167.4K | |
| 2025-05-19 | 2025-05-15 | CVS | Balser Jeffrey R. | Dir | A - Grant | $60.47 | +2,232 | 11.9K | +23% | +$135.0K | |
| 2025-05-19 | 2025-05-15 | CVS | SANSONE GUY P | Dir | A - Grant | $60.47 | +2,077 | 10.4K | +25% | +$125.6K | |
| A | 2025-05-09 | 2025-04-01 | CVS | Joyner J. David | Pres, CEO, Dir | A - Grant | $0.00 | +53.3K | 82.5K | +183% | $0 |
| MI | 2025-05-06 | 2025-05-02+ | CVS | ROBBINS LARRY | Dir | S - Sale | $67.66 | -3.75M | 8.44M | -31% | -$253.71M |
| D | 2025-04-03 | 2025-04-01 | CVS | Nelson Steven H | EVP, Pres, Aetna | A - Grant | $67.98 | +21.3K | 21.3K | New | +$1.45M |
| D | 2025-04-03 | 2025-04-01 | CVS | Joyner J. David | Pres, CEO, Dir | F - Tax | $67.98 | -1,847 | 51.9K | -3% | -$125.6K |
| D | 2025-04-03 | 2025-04-01 | CVS | Khichi Samrat S. | EVP, GC, CPO | F - Tax | $67.98 | -1,548 | 21.7K | -7% | -$105.2K |
| D | 2025-04-03 | 2025-04-01 | CVS | Khichi Samrat S. | EVP, GC, CPO | A - Grant | $67.98 | +16.2K | 41.6K | +64% | +$1.10M |
| D | 2025-04-03 | 2025-04-01 | CVS | COWHEY THOMAS F. | EVP, CFO | F - Tax | $67.98 | -3,203 | 50.2K | -6% | -$217.7K |
| D | 2025-04-03 | 2025-04-01 | CVS | COWHEY THOMAS F. | EVP, CFO | A - Grant | $67.98 | +16.2K | 41.1K | +65% | +$1.10M |
| D | 2025-04-03 | 2025-04-01 | CVS | Shah Prem S | EVP, Group Pres | A - Grant | $67.98 | +26.5K | 58.2K | +84% | +$1.80M |
| D | 2025-04-03 | 2025-04-01 | CVS | Shah Prem S | EVP, Group Pres | F - Tax | $67.98 | -1,308 | 47.3K | -3% | -$88.9K |
| D | 2025-04-03 | 2025-04-01 | CVS | Mandadi Tilak | EVP, Chief Experience, Tech | F - Tax | $67.98 | -995 | 43.5K | -2% | -$67.6K |
| D | 2025-04-03 | 2025-04-01 | CVS | Mandadi Tilak | EVP, Chief Experience, Tech | A - Grant | $67.98 | +20.6K | 116.3K | +22% | +$1.40M |
| D | 2025-04-03 | 2025-04-01 | CVS | CAPOZZI HEIDI B | EVP, CHRO | A - Grant | $67.98 | +11.8K | 95.3K | +14% | +$800.0K |
| 2025-04-03 | 2025-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $67.98 | -2,266 | 11.2K | -17% | -$154.0K | |
| 2025-04-03 | 2025-04-01 | CVS | Clark James David | SVP, Cont, Chief Acct Off | A - Grant | $67.98 | +14.7K | 24.7K | +147% | +$1000.0K | |
| D | 2025-03-18 | 2025-03-17 | CVS | Shah Prem S | EVP, Group Pres | M - OptEx | $62.21 | +846 | 43.2K | +2% | +$52.6K |
| I | 2025-03-14 | 2022-11-18 | CVS | Finucane Anne A. | Dir | G - Gift | $97.35 | -800 | 29.0K | -3% | -$77.9K |
| D | 2025-03-07 | 2025-03-05 | CVS | Clark James David | SVP, Cont, Chief Acct Off | S - Sale+OE | $66.35 | -7,513 | 8,394 | -47% | -$498.5K |
| D | 2025-03-07 | 2025-03-05 | CVS | Clark James David | SVP, Cont, Chief Acct Off | M - OptEx | $62.21 | +7,513 | 15.9K | +90% | +$467.4K |
| 2025-03-03 | 2025-02-28 | CVS | Khichi Samrat S. | EVP, GC, CPO | F - Tax | $65.72 | -5,604 | 20.1K | -22% | -$368.3K | |
| 2025-03-03 | 2025-02-28 | CVS | Joyner J. David | Pres, CEO, Dir | F - Tax | $65.72 | -1,944 | 46.7K | -4% | -$127.8K | |
| 2025-03-03 | 2025-02-28 | CVS | COWHEY THOMAS F. | EVP, CFO | F - Tax | $65.72 | -5,318 | 45.3K | -11% | -$349.5K | |
| 2025-02-19 | 2025-02-18 | CVS | Mahoney Michael F | Dir | P - Purchase | $66.70 | +30.0K | 39.4K | +321% | +$2.00M | |
| 2024-12-09 | 2024-12-05 | CVS | Finucane Anne A. | Dir | G - Gift | $56.86 | -2,665 | 4,567 | -37% | -$151.5K | |
| 2024-12-03 | 2024-11-30 | CVS | FARAH ROGER N | Dir | A - Grant | $59.85 | +50.1K | 50.1K | New | +$3.00M | |
| 2024-12-03 | 2024-11-30 | CVS | Clark James David | SVP, Cont, Chief Acct Off | F - Tax | $59.85 | -86 | 8,394 | -1% | -$5,147 | |
| 2024-12-03 | 2024-11-30 | CVS | Mandadi Tilak | EVP, Chief DDAT Off | A - Grant | $59.85 | +50.1K | 99.7K | +101% | +$3.00M | |
| 2024-12-03 | 2024-11-30 | CVS | CAPOZZI HEIDI B | EVP, CHRO | A - Grant | $59.85 | +83.5K | 83.5K | New | +$5.00M | |
| 2024-11-25 | 2024-11-21 | CVS | Norwalk Leslie V | Dir | A - Grant | $57.10 | +2,200 | 2,200 | New | +$125.6K | |
| 2024-11-25 | 2024-11-21 | CVS | Shulman Douglas H. | Dir | A - Grant | $57.10 | +2,200 | 2,200 | New | +$125.6K | |
| 2024-11-25 | 2024-11-21 | CVS | AGUIRRE FERNANDO | Dir | A - Grant | $57.10 | +2,364 | 36.9K | +7% | +$135.0K | |
| 2024-11-25 | 2024-11-21 | CVS | DEPARLE NANCY ANN | Dir | A - Grant | $57.10 | +2,331 | 34.2K | +7% | +$133.1K | |
| 2024-11-25 | 2024-11-21 | CVS | BROWN C DAVID II | Dir | A - Grant | $57.10 | +2,331 | 123.8K | +2% | +$133.1K | |
| 2024-11-25 | 2024-11-21 | CVS | MILLON JEAN PIERRE | Dir | A - Grant | $57.10 | +2,200 | 4,514 | +95% | +$125.6K | |
| 2024-11-25 | 2024-11-21 | CVS | Balser Jeffrey R. | Dir | A - Grant | $57.10 | +2,375 | 9,652 | +33% | +$135.6K | |
| 2024-11-25 | 2024-11-21 | CVS | KIRBY J SCOTT | Dir | A - Grant | $57.10 | +2,933 | 8,566 | +52% | +$167.5K | |
| 2024-11-25 | 2024-11-21 | CVS | Mahoney Michael F | Dir | A - Grant | $57.10 | +2,200 | 6,201 | +55% | +$125.6K | |
| 2024-11-25 | 2024-11-21 | CVS | SANSONE GUY P | Dir | A - Grant | $57.10 | +2,200 | 8,360 | +36% | +$125.6K | |
| 2024-09-03 | 2024-08-31 | CVS | Mandadi Tilak | EVP, CTO | F - Tax | $57.24 | -13.1K | 40.4K | -24% | -$749.7K |
Purchase Sale Sale after option exercise All abbreviations